期刊文献+

溶血磷脂酰胆碱在动脉粥样硬化中的作用 被引量:26

下载PDF
导出
摘要 溶血磷脂酰胆碱是氧化型低密度脂蛋白的主要活性成分,具有广泛的生物学效应,参与动脉粥样硬化发生发展的各个环节。溶血磷脂酰胆碱可以诱发炎症反应,增加氧化应激,干扰血管内皮功能,破坏斑块稳定性,其生物学活性以及作用机制的阐述对动脉粥样硬化的预防、诊断和治疗具有很重要的作用。
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第12期1083-1086,共4页 Chinese Journal of Arteriosclerosis
  • 相关文献

参考文献28

  • 1Kabarowski JHS,Zhu K,Le LQ,Owen N Witte,Xu Yan.Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A[J].Science,2001,293:702-705
  • 2Parks BW,Lusis AJ,Kabarowski JH.Loss of the lysophosphatidylcholine Effector,G2A,Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice[J].Arterioscler Thromb Vasc Biol,2006,26(12):2 703-709
  • 3Yoshiyuki R,Ken-ichi H,Tomoya Y,Kenji I,Seiichi K,Hiroshi I.Expression of G2A,a receptor for lysophosphatidylcholine,by macrophages in murine,rabbit,and human atherosclerotic plaques[J].Arterioscler Thromb Vasc Biol,2002,22:2 049-053
  • 4Witte ON,Kabarowski JH,Yan Xu,Lu QL,Zhu K.Retraction[J].Science,2005,14(307):206-216
  • 5Zhu K,Baudhuin LM,Hong GY,Williams FS,Cristina KL,Kabarowski JHS,et al.Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4[J].J Biol Chem,2001,276:41 325-335
  • 6Yun MR,Okajima F,Im DS.The action mode of lysophosphatidylcholine in human monocytes[J].J Pharmacol Sci,2004,94:45-50
  • 7Yan S,Chai H,Wang H,Yang H,Nan B,Yao Q.Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cell[J].Surgery,2005,138:464-473
  • 8梁英,刘同涛,田庆印.氨氯地平对溶血磷脂酰胆碱致培养人脐静脉内皮细胞损伤的保护作用[J].齐鲁医学杂志,2004,19(5):408-409. 被引量:2
  • 9孙国举,谢秀梅,邢莹,鄢文海,杨天崙,余国龙.非诺贝特对LPC诱导脐静脉内皮细胞增殖、凋亡及eNOS基因表达的影响[J].中南大学学报(医学版),2006,31(3):373-378. 被引量:4
  • 10田庆印,刘同涛,李伯勤,潘其兴,朱清.普罗布考对溶血磷脂酰胆碱致培养人脐静脉内皮细胞损伤的保护作用[J].中国动脉硬化杂志,2003,11(3):211-213. 被引量:10

二级参考文献31

  • 1王克勤 何锦麟.一次性密度梯度超速离心分离人血清的VLDL、LDL、HDL2、HDL3及无脂血清[J].生物化学杂志,1986,2(1):15-22.
  • 2沈德钧 吴伟 等.中国地鼠卵巢细胞和巨噬细胞的培养.现代医学实验方法(第1版)[M].北京:人民卫生出版社,1997.174-175.
  • 3刘国庆 宋武.培养细胞微量胆固醇及其酯的酶-荧光检测法[J].中国病理生理杂志,1987,3(3):185-187.
  • 4Berliner JA,Heinecke W. The role of oxidized lipoproteins in atherogenesis[J].Free Radic Biol Med,1996,20(5):707.
  • 5Kugiyama K, Sakamoto T, Misumi I, et al. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells[J]. Circ Res, 1993,73:335.
  • 6Beaudeux JL, Therond P, Bonnefont-Rousselot D,et al. Comparison of the effects of O-2/HO- free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1[J]. Life Sci, 2001, 69:2371.
  • 7Dichtl W, Stiko A, Eriksson P, et al. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 1999,19:3025.
  • 8[2]Brasen JH, Koenig K, Bach H, Kontush A, Heinle H, Witting PK, et al. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. Atherosclerosis, 2002, 163: 249-259
  • 9[3]Beaudeux JL, Therond P, Bonnefont RD, Gardes AM, Legrand A, Delattre J, et al. Comparison of the effects of O2 /HO free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1. Life Sci, 2001, 69: 2 371-382
  • 10[4]Dichtl W, Stiko A, Eriksson P, Goncalves I, Calara F, Banfi C, et al. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999, 19: 3 025-032

共引文献16

同被引文献253

引证文献26

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部